Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease.
|
J Clin Invest
|
2004
|
3.47
|
2
|
Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations.
|
Cancer Cell
|
2005
|
2.51
|
3
|
Unknown complication of arterial switch operation: resistant hypertension induced by a strong aortic arch angulation.
|
Circulation
|
2013
|
2.02
|
4
|
Selection and persistence of viral resistance in HIV-infected children after exposure to single-dose nevirapine.
|
J Acquir Immune Defic Syndr
|
2007
|
1.87
|
5
|
PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder.
|
Proc Natl Acad Sci U S A
|
2004
|
1.81
|
6
|
Fundulus as the premier teleost model in environmental biology: opportunities for new insights using genomics.
|
Comp Biochem Physiol Part D Genomics Proteomics
|
2007
|
1.52
|
7
|
FGFR3 as a therapeutic target of the small molecule inhibitor PKC412 in hematopoietic malignancies.
|
Oncogene
|
2005
|
1.32
|
8
|
Oncogenic K-ras cooperates with PML-RAR alpha to induce an acute promyelocytic leukemia-like disease.
|
Blood
|
2006
|
1.17
|
9
|
Malnutrition determined by the patient-generated subjective global assessment is associated with poor outcomes in acute stroke patients.
|
Clin Nutr
|
2005
|
1.07
|
10
|
Racial differences in the association between body mass index and serum IGF1, IGF2, and IGFBP3.
|
Endocr Relat Cancer
|
2010
|
1.06
|
11
|
A cohort study of Parkinson's disease and other neurodegenerative disorders in Danish welders.
|
J Occup Environ Med
|
2005
|
1.05
|
12
|
Women exposed to single-dose nevirapine in successive pregnancies: effectiveness and nonnucleoside reverse transcriptase inhibitor resistance.
|
AIDS
|
2009
|
1.00
|
13
|
Homing in on depression genes.
|
Am J Psychiatry
|
2007
|
0.90
|
14
|
Parvoviruses cause nuclear envelope breakdown by activating key enzymes of mitosis.
|
PLoS Pathog
|
2013
|
0.90
|
15
|
Primary care physicians, office-based practice, and the meaning of quality improvement.
|
Am J Med
|
2005
|
0.89
|
16
|
Laparoendoscopic single-site surgery in gynecology.
|
Curr Opin Obstet Gynecol
|
2010
|
0.88
|
17
|
Microinjection of Xenopus laevis oocytes as a system for studying nuclear transport of viruses.
|
Methods
|
2010
|
0.84
|
18
|
Association of the serotonin transporter gene, neuroticism and smoking behaviours.
|
J Hum Genet
|
2008
|
0.81
|
19
|
Hysteroscopic morcellation for treating intrauterine pathology.
|
Rev Obstet Gynecol
|
2011
|
0.78
|
20
|
Key issues of daily life in adults with congenital heart disease.
|
Arch Cardiovasc Dis
|
2013
|
0.77
|
21
|
Evolution of tolerance to PCBs and susceptibility to a bacterial pathogen (Vibrio harveyi) in Atlantic killifish (Fundulus heteroclitus) from New Bedford (MA, USA) harbor.
|
Environ Pollut
|
2008
|
0.77
|
22
|
An interrupted time series evaluation of a hepatitis C intervention for persons with HIV.
|
AIDS Behav
|
2011
|
0.77
|
23
|
Health Care Disparities in Hysterectomy for Gynecologic Cancers: Data From the 2012 National Inpatient Sample.
|
Obstet Gynecol
|
2015
|
0.76
|
24
|
A randomized controlled trial of health information exchange between human immunodeficiency virus institutions.
|
J Public Health Manag Pract
|
2010
|
0.76
|
25
|
Proteomic analysis identifies a novel function for galectin-3 in the cell entry of parvovirus.
|
J Proteomics
|
2012
|
0.76
|
26
|
Endovascular treatment of peripheral aneurysms in Kawasaki disease.
|
Arch Cardiovasc Dis
|
2013
|
0.75
|
27
|
Partial anomalous pulmonary venous return in adults with prior curative congenital heart surgery detected by cross-sectional imaging techniques.
|
Int J Cardiol
|
2013
|
0.75
|
28
|
[Heart disease and pregnancy].
|
Rev Prat
|
2012
|
0.75
|
29
|
Best practices in hospital end-of-life care.
|
Conn Med
|
2002
|
0.75
|
30
|
[Contraception and congenital heart disease].
|
Rev Prat
|
2013
|
0.75
|
31
|
Diagnosis, surveillance, and treatment of the anemic fetus using middle cerebral artery peak systolic velocity measurement.
|
Prenat Diagn
|
2006
|
0.75
|